{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:43Z","timestamp":1792785043311,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":62,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fulbright U.S. Student Program"},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["1F31MD020275"],"award-info":[{"award-number":["1F31MD020275"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["L60MD01432"],"award-info":[{"award-number":["L60MD01432"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005088","name":"Ohio Cancer Research Associates","doi-asserted-by":"publisher","award":["ECIG-2022-3-1143"],"award-info":[{"award-number":["ECIG-2022-3-1143"]}],"id":[{"id":"10.13039\/100005088","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Cancer Institute","award":["5P30CA006927"],"award-info":[{"award-number":["5P30CA006927"]}]},{"name":"Chan Zuckerberg Initiative Ancestry Network","award":["DAF2021-240624"],"award-info":[{"award-number":["DAF2021-240624"]}],"id":[{"id":"https:\/\/ror.org\/02qenvm24","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Health Fund, Jamaica","id":[{"id":"https:\/\/ror.org\/03engbs88","id-type":"ROR","asserted-by":"crossref"}]},{"name":"NIH Emerging Global Leader Award","award":["K43 TW011387-01A1"],"award-info":[{"award-number":["K43 TW011387-01A1"]}]},{"name":"the Principal\u2019s New Initiative grant, The UWI, Mona"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51649-x","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T21:02:55Z","timestamp":1778101375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Establishing the first Afro-Caribbean breast cancer cell lines reveals ECM pathway enrichment and distinctive drug sensitivities"],"prefix":"10.1038","volume":"16","author":[{"given":"Shannique","family":"Clarke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovanka","family":"Ravix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maycon","family":"Mar\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Carcanholo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Doughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Sanchez-Covarrubias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derria","family":"Cornwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude-Henry","family":"Volmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Saigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bilbao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Ragin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Badal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"key":"51649_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41597-023-02253-5","volume":"10","author":"Y Xu","year":"2023","unstructured":"Xu, Y. et al. Global trends and forecasts of breast cancer incidence and deaths. Sci. Data. 10, 334. https:\/\/doi.org\/10.1038\/s41597-023-02253-5 (2023).","journal-title":"Sci. Data."},{"key":"51649_CR2","unstructured":"World Health Organization. Breast cancer, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/breast-cancer (2023)."},{"key":"51649_CR3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3322\/caac.21754","volume":"72","author":"AN Giaquinto","year":"2022","unstructured":"Giaquinto, A. N. et al. Breast cancer statistics, 2022. CA. Cancer J. Clin. 72, 524\u2013541. https:\/\/doi.org\/10.3322\/caac.21754 (2022).","journal-title":"CA. Cancer J. Clin."},{"key":"51649_CR4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17042","volume":"13","author":"K Samaroo","year":"2021","unstructured":"Samaroo, K., Hosein, A., Olivier, L. K. & Ali, J. Breast cancer in the Caribbean. Cureus 13, e17042. https:\/\/doi.org\/10.7759\/cureus.17042 (2021).","journal-title":"Cureus"},{"key":"51649_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-3-030-20301-6_3","volume":"1152","author":"CG Yedjou","year":"2019","unstructured":"Yedjou, C. G. et al. Health and racial disparity in breast cancer. Adv. Exp. Med. Biol. 1152, 31\u201349. https:\/\/doi.org\/10.1007\/978-3-030-20301-6_3 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"51649_CR6","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1001\/jamaoncol.2017.0595","volume":"3","author":"D Huo","year":"2017","unstructured":"Huo, D. et al. Comparison of breast cancer molecular features and survival by African and European ancestry in The Cancer Genome Atlas. JAMA. Oncol. 3, 1654\u20131662. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0595 (2017).","journal-title":"JAMA. Oncol."},{"key":"51649_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-022-01533-z","volume":"24","author":"SD Siegel","year":"2022","unstructured":"Siegel, S. D. et al. Racial disparities in triple negative breast cancer: Toward a causal architecture approach. Breast Cancer Res. 24, 37. https:\/\/doi.org\/10.1186\/s13058-022-01533-z (2022).","journal-title":"Breast Cancer Res."},{"key":"51649_CR8","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1158\/2159-8290.Cd-22-0138","volume":"12","author":"R Martini","year":"2022","unstructured":"Martini, R. et al. African ancestry-associated gene expression profiles in triple-negative breast cancer underlie altered tumor biology and clinical outcome in women of African descent. Cancer Discov. 12, 2530\u20132551. https:\/\/doi.org\/10.1158\/2159-8290.Cd-22-0138 (2022).","journal-title":"Cancer Discov."},{"key":"51649_CR9","doi-asserted-by":"publisher","unstructured":"Matias, A. T. et al. Differential expression between African-ancestry and White patients diagnosed with Triple-Negative Breast Cancer: EGFR, Myc, Bcl2 and \u03b2-Catenin as ancestry-associated markers. bioRxiv, 2020.2011.2013.381608 (2020). https:\/\/doi.org\/10.1101\/2020.11.13.381608","DOI":"10.1101\/2020.11.13.381608"},{"key":"51649_CR10","unstructured":"Daniela, F., Filomena, A. & Raquel, C. in Oncogenomics and Cancer Proteomics (eds L\u00f3pez-Camarillo C\u00e9sar & Ar\u00e9chaga-Ocampo Elena) Ch. 6 (IntechOpen, 2013)."},{"key":"51649_CR11","doi-asserted-by":"publisher","first-page":"5115","DOI":"10.1073\/pnas.77.9.5115","volume":"77","author":"GL Greene","year":"1980","unstructured":"Greene, G. L., Nolan, C., Engler, J. P. & Jensen, E. V. Monoclonal antibodies to human estrogen receptor. Proc. Natl. Acad. Sci. U. S. A. 77, 5115\u20135119. https:\/\/doi.org\/10.1073\/pnas.77.9.5115 (1980).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"51649_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13058-022-01551-x","volume":"24","author":"S Clarke","year":"2022","unstructured":"Clarke, S., Chin, S. N., Dodds, L., George, S. H. L. & Badal, S. Racial disparities in breast cancer preclinical and clinical models. Breast Cancer Res. 24, 56. https:\/\/doi.org\/10.1186\/s13058-022-01551-x (2022).","journal-title":"Breast Cancer Res."},{"key":"51649_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3233\/bd-2010-0307","volume":"32","author":"KJ Chavez","year":"2010","unstructured":"Chavez, K. J., Garimella, S. V. & Lipkowitz, S. Triple negative breast cancer cell lines: One tool in the search for better treatment of triple negative breast cancer. Breast Dis. 32, 35\u201348. https:\/\/doi.org\/10.3233\/bd-2010-0307 (2010).","journal-title":"Breast Dis."},{"key":"51649_CR14","doi-asserted-by":"publisher","DOI":"10.15252\/msb.202211017","volume":"18","author":"L Trastulla","year":"2022","unstructured":"Trastulla, L., Noorbakhsh, J., Vazquez, F., McFarland, J. & Iorio, F. Computational estimation of quality and clinical relevance of cancer cell lines. Mol. Syst. Biol. 18, e11017. https:\/\/doi.org\/10.15252\/msb.202211017 (2022).","journal-title":"Mol. Syst. Biol."},{"key":"51649_CR15","unstructured":"CARPHA. Breast Cancer: the No. 1 Killer Among Females in the Caribbean https:\/\/carpha.org\/More\/Media\/Articles\/ArticleID\/231\/Breast-Cancer-the-No-1-Killer-Among-Females-in-the-Caribbean (2018)."},{"key":"51649_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41391-020-00274-4","volume":"24","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Immortalization of human primary prostate epithelial cells via CRISPR inactivation of the CDKN2A locus and expression of telomerase. Prostate Cancer Prostatic Dis. 24, 233\u2013243. https:\/\/doi.org\/10.1038\/s41391-020-00274-4 (2021).","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"51649_CR17","unstructured":"Addgene. Addgene: Virus Protocol - Generating Stable Cell Lines https:\/\/www.addgene.org\/protocols\/generating-stable-cell-lines\/ (2023)."},{"key":"51649_CR18","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1158\/2767-9764.crc-22-0245","volume":"2","author":"H Valentine","year":"2022","unstructured":"Valentine, H. et al. Expanding the prostate cancer cell line repertoire with ACRJ-PC28, an AR-negative neuroendocrine cell line derived from an African-Caribbean patient. Cancer Res. Commun. 2, 1355\u20131371. https:\/\/doi.org\/10.1158\/2767-9764.crc-22-0245 (2022).","journal-title":"Cancer Res. Commun."},{"key":"51649_CR19","first-page":"63","volume":"8","author":"KN ArulJothi","year":"2019","unstructured":"ArulJothi, K. N. et al. Papanicolaou stain. Int. J. Sci. Res. 8, 63\u201365 (2019).","journal-title":"Int. J. Sci. Res."},{"key":"51649_CR20","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot4986","author":"AH Fischer","year":"2008","unstructured":"Fischer, A. H., Jacobson, K. A., Rose, J. & Zeller, R. Hematoxylin and eosin staining of tissue and cell sections. Cold Spring Harb. Protoc. https:\/\/doi.org\/10.1101\/pdb.prot4986 (2008).","journal-title":"Cold Spring Harb. Protoc."},{"key":"51649_CR21","volume-title":"Theory and Practice of Histological Techniques","author":"JD Bancroft","year":"2013","unstructured":"Bancroft, J. D. & Gamble, M. Theory and Practice of Histological Techniques 7th edn. (Churchill Livingstone, 2013).","edition":"7"},{"key":"51649_CR22","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1002\/cyto.a.20333","volume":"69","author":"HT Maecker","year":"2006","unstructured":"Maecker, H. T. & Trotter, J. Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A 69, 1037\u20131042. https:\/\/doi.org\/10.1002\/cyto.a.20333 (2006).","journal-title":"Cytometry A"},{"key":"51649_CR23","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1016\/j.cell.2022.08.004","volume":"185","author":"M Byrska-Bishop","year":"2022","unstructured":"Byrska-Bishop, M. et al. High-coverage whole-genome sequencing of the expanded 1000 Genomes Project cohort including 602 trios. Cell 185, 3426-3440.e3419. https:\/\/doi.org\/10.1016\/j.cell.2022.08.004 (2022).","journal-title":"Cell"},{"key":"51649_CR24","unstructured":"Gencove. Human Ancestry Reference Populations, https:\/\/resources.gencove.com\/hc\/en-us\/articles\/7267880409883-Human-Ancestry-Reference-Populations (2023)."},{"key":"51649_CR25","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589\u2013595. https:\/\/doi.org\/10.1093\/bioinformatics\/btp698 (2010).","journal-title":"Bioinformatics"},{"key":"51649_CR26","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303. https:\/\/doi.org\/10.1101\/gr.107524.110 (2010).","journal-title":"Genome Res."},{"key":"51649_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang, K., Li, M. & Hakonarson, H. ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164. https:\/\/doi.org\/10.1093\/nar\/gkq603 (2010).","journal-title":"Nucleic Acids Res."},{"key":"51649_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/cpmc.60","volume":"50","author":"M Gulati","year":"2018","unstructured":"Gulati, M. et al. In vitro culturing and screening of Candida albicans biofilms. Curr. Protoc. Microbiol. 50, e60. https:\/\/doi.org\/10.1002\/cpmc.60 (2018).","journal-title":"Curr. Protoc. Microbiol."},{"key":"51649_CR29","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1158\/0008-5472.Can-17-2040","volume":"78","author":"S Mustafi","year":"2018","unstructured":"Mustafi, S. et al. Vitamin C sensitizes melanoma to BET inhibitors. Cancer Res. 78, 572\u2013583. https:\/\/doi.org\/10.1158\/0008-5472.Can-17-2040 (2018).","journal-title":"Cancer Res."},{"key":"51649_CR30","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.21873\/anticanres.13558","volume":"39","author":"I Lohse","year":"2019","unstructured":"Lohse, I. et al. Ovarian cancer treatment stratification using ex vivo drug sensitivity testing. Anticancer Res. 39, 4023\u20134030. https:\/\/doi.org\/10.21873\/anticanres.13558 (2019).","journal-title":"Anticancer Res."},{"key":"51649_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174094","author":"JL Dennison","year":"2022","unstructured":"Dennison, J. L. et al. Functional drug screening of small molecule inhibitors of epigenetic modifiers in refractory AML patients. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers14174094 (2022).","journal-title":"Cancers (Basel)"},{"key":"51649_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ijc.24999","volume":"126","author":"WG Dirks","year":"2010","unstructured":"Dirks, W. G. et al. Cell line cross-contamination initiative: An interactive reference database of STR profiles covering common cancer cell lines. Int. J. Cancer 126, 303\u2013304 (2010).","journal-title":"Int. J. Cancer"},{"key":"51649_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7171\/jbt.18-2902-002","volume":"29","author":"A Bairoch","year":"2018","unstructured":"Bairoch, A. The Cellosaurus, a cell-line knowledge resource. J. Biomol. Tech. 29, 25\u201338 (2018).","journal-title":"J. Biomol. Tech."},{"key":"51649_CR34","first-page":"2929","volume":"5","author":"X Dai","year":"2015","unstructured":"Dai, X. et al. Breast cancer intrinsic subtype classification, clinical use and future trends. Am J Cancer Res 5, 2929\u20132943 (2015).","journal-title":"Am J Cancer Res"},{"key":"51649_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114433","volume":"43","author":"HA Anagho","year":"2024","unstructured":"Anagho, H. A. et al. ADP-ribosylome analysis reveals homogeneous DNA-damage-induced serine ADP-ribosylation across wild-type and BRCA-mutant breast cancer cell lines. Cell Rep. 43, 114433 (2024).","journal-title":"Cell Rep."},{"key":"51649_CR36","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1038\/sj.bjc.6605335","volume":"101","author":"LY Lim","year":"2009","unstructured":"Lim, L. Y., Vidnovic, N., Ellisen, L. W. & Leong, C. O. Mutant p53 mediates survival of breast cancer cells. Br. J. Cancer 101, 1606\u20131612 (2009).","journal-title":"Br. J. Cancer"},{"key":"51649_CR37","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1002\/stem.2021","volume":"33","author":"PS Thiagarajan","year":"2015","unstructured":"Thiagarajan, P. S. et al. Development of a fluorescent reporter system to delineate cancer stem cells in Triple-Negative Breast Cancer. Stem Cells 33, 2114\u20132125. https:\/\/doi.org\/10.1002\/stem.2021 (2015).","journal-title":"Stem Cells"},{"key":"51649_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051239","volume":"12","author":"R Vikram","year":"2020","unstructured":"Vikram, R., Chou, W. C., Hung, S. C. & Shen, C. Y. Tumorigenic and metastatic role of CD44(-\/low)\/CD24(-\/low) cells in Luminal Breast Cancer. Cancers (Basel) 12, 12051239 (2020).","journal-title":"Cancers (Basel)"},{"key":"51649_CR39","first-page":"1139","volume":"46","author":"EY Lasfargues","year":"1971","unstructured":"Lasfargues, E. Y. & Ozellos, L. Culture of human breast carcinoma cells. J. Natl. Cancer Inst. 46, 1139\u20131144 (1971).","journal-title":"J. Natl. Cancer Inst."},{"key":"51649_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-024-10202-w","author":"C James","year":"2024","unstructured":"James, C., Whitehead, A., Plummer, J. T., Thompson, R. & Badal, S. Failure to progress: Breast and prostate cancer cell lines in developing targeted therapies. Cancer Metastasis Rev. https:\/\/doi.org\/10.1007\/s10555-024-10202-w (2024).","journal-title":"Cancer Metastasis Rev."},{"key":"51649_CR41","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/bjc.1996.521","volume":"74","author":"JJ Pink","year":"1996","unstructured":"Pink, J. J., Bilimoria, M. M., Assikis, J. & Jordan, V. C. Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivation. Br. J. Cancer 74, 1227\u20131236 (1996).","journal-title":"Br. J. Cancer"},{"key":"51649_CR42","first-page":"2321","volume":"56","author":"JJ Pink","year":"1996","unstructured":"Pink, J. J. & Jordan, V. C. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Res. 56, 2321\u20132330 (1996).","journal-title":"Cancer Res."},{"key":"51649_CR43","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1073\/pnas.83.8.2496","volume":"83","author":"Y Berthois","year":"1986","unstructured":"Berthois, Y., Katzenellenbogen, J. A. & Katzenellenbogen, B. S. Phenol red in tissue culture media is a weak estrogen: Implications concerning the study of estrogen-responsive cells in culture. Proc. Natl. Acad. Sci. U. S. A. 83, 2496\u20132500 (1986).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"51649_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-025-02032-7","volume":"27","author":"SC Kim","year":"2025","unstructured":"Kim, S. C. et al. Establishment and characterization of 24 breast cancer cell lines and 3 breast cancer organoids reveals molecular heterogeneity and drug response variability in malignant pleural effusion-derived models. Breast Cancer Res. 27, 66. https:\/\/doi.org\/10.1186\/s13058-025-02032-7 (2025).","journal-title":"Breast Cancer Res."},{"key":"51649_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2635","volume":"12","author":"A Prat","year":"2010","unstructured":"Prat, A. et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 12, R68. https:\/\/doi.org\/10.1186\/bcr2635 (2010).","journal-title":"Breast Cancer Res."},{"key":"51649_CR46","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.1158\/0008-5472.Can-08-3441","volume":"69","author":"BT Hennessy","year":"2009","unstructured":"Hennessy, B. T. et al. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res. 69, 4116\u20134124. https:\/\/doi.org\/10.1158\/0008-5472.Can-08-3441 (2009).","journal-title":"Cancer Res."},{"key":"51649_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cells12232712","author":"S Zheng","year":"2023","unstructured":"Zheng, S., Guerrero-Haughton, E. & Foijer, F. Chromosomal instability-driven cancer progression: Interplay with the tumour microenvironment and therapeutic strategies. Cells https:\/\/doi.org\/10.3390\/cells12232712 (2023).","journal-title":"Cells"},{"key":"51649_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1450614","volume":"12","author":"SA Baba","year":"2024","unstructured":"Baba, S. A., Zakeri, A. & Desgrosellier, J. S. Chromosomal instability as an architect of the cancer stemness landscape. Front. Cell Dev. Biol. 12, 1450614. https:\/\/doi.org\/10.3389\/fcell.2024.1450614 (2024).","journal-title":"Front. Cell Dev. Biol."},{"key":"51649_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1292775","volume":"11","author":"I Jahin","year":"2023","unstructured":"Jahin, I. et al. Extracellular matrix stiffness activates mechanosensitive signals but limits breast cancer cell spheroid proliferation and invasion. Front. Cell Dev. Biol. 11, 1292775. https:\/\/doi.org\/10.3389\/fcell.2023.1292775 (2023).","journal-title":"Front. Cell Dev. Biol."},{"key":"51649_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00544-0","volume":"6","author":"J Huang","year":"2021","unstructured":"Huang, J. et al. Extracellular matrix and its therapeutic potential for cancer treatment. Signal Transduct. Target. Ther. 6, 153. https:\/\/doi.org\/10.1038\/s41392-021-00544-0 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"51649_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2019.00160","volume":"6","author":"E Henke","year":"2019","unstructured":"Henke, E., Nandigama, R. & Erg\u00fcn, S. Extracellular matrix in the tumor microenvironment and its impact on cancer therapy. Front. Mol. Biosci. 6, 160. https:\/\/doi.org\/10.3389\/fmolb.2019.00160 (2019).","journal-title":"Front. Mol. Biosci."},{"key":"51649_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-022-02484-1","volume":"41","author":"A Jurj","year":"2022","unstructured":"Jurj, A., Ionescu, C., Berindan-Neagoe, I. & Braicu, C. The extracellular matrix alteration, implication in modulation of drug resistance mechanism: Friends or foes?. J. Exp. Clin. Cancer Res. 41, 276. https:\/\/doi.org\/10.1186\/s13046-022-02484-1 (2022).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"51649_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.650453","volume":"11","author":"Y Zhao","year":"2021","unstructured":"Zhao, Y. et al. Extracellular matrix: Emerging roles and potential therapeutic targets for breast cancer. Front. Oncol. 11, 650453. https:\/\/doi.org\/10.3389\/fonc.2021.650453 (2021).","journal-title":"Front. Oncol."},{"key":"51649_CR54","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1093\/jnci\/91.21.1876","volume":"91","author":"JR Mackey","year":"1999","unstructured":"Mackey, J. R. et al. Gemcitabine transport in Xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters. J. Natl. Cancer Inst. 91, 1876\u20131881. https:\/\/doi.org\/10.1093\/jnci\/91.21.1876 (1999).","journal-title":"J. Natl. Cancer Inst."},{"key":"51649_CR55","first-page":"819","volume":"3","author":"Y Saiki","year":"2020","unstructured":"Saiki, Y., Hirota, S. & Horii, A. Attempts to remodel the pathways of gemcitabine metabolism: Recent approaches to overcoming tumours with acquired chemoresistance. Cancer Drug Resist. 3, 819\u2013831 (2020).","journal-title":"Cancer Drug Resist."},{"key":"51649_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.965244","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang, X., Huo, X., Guo, H. & Xue, L. Combined inhibition of PARP and EZH2 for cancer treatment: Current status, opportunities, and challenges. Front. Pharmacol. 13, 965244. https:\/\/doi.org\/10.3389\/fphar.2022.965244 (2022).","journal-title":"Front. Pharmacol."},{"key":"51649_CR57","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1093\/jnci\/djaa040","volume":"112","author":"JR Palmer","year":"2020","unstructured":"Palmer, J. R. et al. Contribution of germline predisposition gene mutations to breast cancer risk in African American women. J. Natl. Cancer Inst. 112, 1213\u20131221. https:\/\/doi.org\/10.1093\/jnci\/djaa040 (2020).","journal-title":"J. Natl. Cancer Inst."},{"key":"51649_CR58","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/cncr.29615","volume":"122","author":"JE Churpek","year":"2016","unstructured":"Churpek, J. E. et al. Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia. Cancer 122, 304\u2013311. https:\/\/doi.org\/10.1002\/cncr.29615 (2016).","journal-title":"Cancer"},{"key":"51649_CR59","doi-asserted-by":"publisher","first-page":"3764","DOI":"10.1158\/1078-0432.Ccr-15-2477","volume":"22","author":"ML Telli","year":"2016","unstructured":"Telli, M. L. et al. Homologous recombination deficiency (HRD) score predicts response to platinum-containing neoadjuvant chemotherapy in patients with Triple-Negative Breast Cancer. Clin. Cancer Res. 22, 3764\u20133773. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-15-2477 (2016).","journal-title":"Clin. Cancer Res."},{"key":"51649_CR60","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1001\/jamaoncol.2021.1254","volume":"7","author":"B Cho","year":"2021","unstructured":"Cho, B. et al. Evaluation of racial\/ethnic differences in treatment and mortality among women with Triple-Negative Breast Cancer. JAMA Oncol. 7, 1016\u20131023. https:\/\/doi.org\/10.1001\/jamaoncol.2021.1254 (2021).","journal-title":"JAMA Oncol."}],"updated-by":[{"DOI":"10.1038\/s41598-026-74921-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51649-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51649-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51649-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:59:53Z","timestamp":1791464393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51649-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51649"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51649-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-74921-6","URL":"https:\/\/doi.org\/10.1038\/s41598-026-74921-6","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with protocols approved by the Institutional Animal Care and Use Committees of the University of Miami. This study was approved by the Ethics Committees of the University of the West Indies, Mona (ECP 88, 16\/17) and the Ministry of Health and Wellness, Jamaica (2020\/52). All procedures involving human participants were performed in accordance with the ethical standards of the institutional research committees and with the 1964 Helsinki Declaration and its later amendments. All participants provided written informed consent before enrolment.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided written informed consent for the publication of their data as part of the study enrolment process. The consent included permission to publish clinical and molecular data in anonymized form.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"20954"}}